Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curdin Conrad

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
The British Journal of Dermatology|December 23, 2021
The biological basis of disease recurrence in psoriasis: a historical perspective and current modelsLluís Puig, Antonio Costanzo, Ernesto J Muñoz-Elías, et al.
Journal of the Peripheral Nervous System : JPNS|April 29, 2023
A severe case of neuroleukemiosis caused by B cell chronic lymphocytic leukemia, presenting as mononeuritis multiplexAlex Vicino, Stéphane Cochet, Silvia Pistocchi, et al.
European Journal of Immunology|October 22, 2014
Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNARoberto Lande, Georgios Chamilos, Dipyaman Ganguly, et al.
Dermatology and Therapy|May 17, 2020
Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)Norman Wasel, Diamant Thaçi, Lars E French, et al.
JAMA Dermatology|January 26, 2017
Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra PilarisLaurence Feldmeyer, Alessio Mylonas, Olivier Demaria, et al.
Journal of the American Academy of Dermatology|February 25, 2020
Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumabSaxon D Smith, Curdin Conrad, Michael Ramharter, et al.
Antibodies (Basel, Switzerland)|April 3, 2021
New Autoantibody Specificities in Systemic Sclerosis and Very Early Systemic SclerosisRoberto Lande, Raffaella Palazzo, Anna Mennella, et al.
Dermatology (Basel, Switzerland)|February 27, 2016
PASS Syndrome: An IL-1-Driven Autoinflammatory DiseaseMathieu Leuenberger, Jeanne Berner, Julie Di Lucca, et al.
European Journal of Dermatology : EJD|August 12, 2008
Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndromeJoanna Mangana, Marie C Zipser, Curdin Conrad, et al.
The Journal of Allergy and Clinical Immunology|February 19, 2026
Molecular profiling of inflammatory palmoplantar disorders for diagnosis and treatment optimizationTeofila Seremet, Antoine Girardin, Ahmad Yatim, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
The British Journal of Dermatology|December 23, 2021
The biological basis of disease recurrence in psoriasis: a historical perspective and current modelsLluís Puig, Antonio Costanzo, Ernesto J Muñoz-Elías, et al.
Journal of the Peripheral Nervous System : JPNS|April 29, 2023
A severe case of neuroleukemiosis caused by B cell chronic lymphocytic leukemia, presenting as mononeuritis multiplexAlex Vicino, Stéphane Cochet, Silvia Pistocchi, et al.
European Journal of Immunology|October 22, 2014
Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNARoberto Lande, Georgios Chamilos, Dipyaman Ganguly, et al.
Dermatology and Therapy|May 17, 2020
Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)Norman Wasel, Diamant Thaçi, Lars E French, et al.
JAMA Dermatology|January 26, 2017
Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra PilarisLaurence Feldmeyer, Alessio Mylonas, Olivier Demaria, et al.
Journal of the American Academy of Dermatology|February 25, 2020
Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumabSaxon D Smith, Curdin Conrad, Michael Ramharter, et al.
Antibodies (Basel, Switzerland)|April 3, 2021
New Autoantibody Specificities in Systemic Sclerosis and Very Early Systemic SclerosisRoberto Lande, Raffaella Palazzo, Anna Mennella, et al.
Dermatology (Basel, Switzerland)|February 27, 2016
PASS Syndrome: An IL-1-Driven Autoinflammatory DiseaseMathieu Leuenberger, Jeanne Berner, Julie Di Lucca, et al.
European Journal of Dermatology : EJD|August 12, 2008
Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndromeJoanna Mangana, Marie C Zipser, Curdin Conrad, et al.
The Journal of Allergy and Clinical Immunology|February 19, 2026
Molecular profiling of inflammatory palmoplantar disorders for diagnosis and treatment optimizationTeofila Seremet, Antoine Girardin, Ahmad Yatim, et al.
Pageof 12